U-Blot® Research Grade BempikibartCat. No. WA2500$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade BempikibartCat. No. WA2500
U-Blot® Research Grade Bemiltenase AlfaCat. No. WA2499
U-Blot® Research Grade BemarituzumabCat. No. WA2498
U-Blot® Research Grade BeludavimabCat. No. WA2497
U-Blot® Research Grade BelrestotugCat. No. WA2496
U-Blot® Research Grade BelimumabCat. No. WA2495
U-Blot® Research Grade BelataceptCat. No. WA2494
U-Blot® Research Grade BelantamabCat. No. WA2493
U-Blot® Research Grade BegelomabCat. No. WA2492
U-Blot® Research Grade BefovacimabCat. No. WA2491
U-Blot® Research Grade BedinvetmabCat. No. WA2490
U-Blot® Research Grade BectumomabCat. No. WA2489